New diagnostic tool could simplify low sodium treatment for blood pressure patients
NCT ID NCT06381934
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether two new measurements, aSID and ChU, can help doctors better diagnose and treat low sodium levels in hospitalized patients taking thiazide diuretics for high blood pressure. Researchers will compare outcomes in 136 patients randomly assigned to either standard care or treatment guided by these new indices. The goal is to see if the new approach works as well or better than current methods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Diagnostic indices (aSID and ChU) used to guide therapy decisions
- What this could lead to
- If successful, this could make diagnosing and treating low sodium faster and more accurate for patients on thiazide diuretics, potentially reducing complications.
- What could go wrong
- This is a small, early-stage study (136 participants) focused on diagnostic accuracy, not a treatment itself. The new method may not outperform standard care in real-world settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THIAZIDE ASSOCIATED HYPONATREMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital Basel
RECRUITINGBasel, 4031, Switzerland